Online ISSN: 1947-6027
www.genesandcancer.com
About Genes & Cancer
Our mission is to combine research from the fields of genomics, bioinformatics, and modem genetics to determine how cancer cells overcome growth regulatory pathways. We aim to cover all aspects of oncogenes, growth suppressor and apoptotic genes, and their roles in tumor development.

LEARN MORE ABOUT GENES & CANCER

Genes & Cancer | Splice modulating oligomers as cancer therapeutics

Genes & Cancer

October 14, 2022
PRESS RELEASE: A new editorial paper was published in Genes & Cancer on August 26, 2022, entitled, “Splice modulating oligomers as cancer therapeutics.” continue reading »

Behind the Study: Reaching Beyond Family History as Inclusion Criteria for Pancreatic Cancer Surveillance in High-risk Populations

Genes & Cancer

October 6, 2022
Dr. Louise Wang from Yale School of Medicine and the VA Connecticut Healthcare system, describes a recent editorial she co-authored that was published by Genes & Cancer, entitled, “Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations.” continue reading »

Genes & Cancer | Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations

Genes & Cancer

September 30, 2022
PRESS RELEASE: A new editorial paper was published in Genes & Cancer on August 29, 2022, entitled, “Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations.” continue reading »

Cell Cycle Mechanism as Potential Target to Treat Array of Cancers

Genes & Cancer

September 12, 2022
In a recently published Genes & Cancer review paper, researchers discuss the role of CDK4 in cell cycle control, normal development, tumorigenesis, and cancer therapeutics. continue reading »

Genes & Cancer | Using Quantitative Immunohistochemistry in Patients at High Risk for Hepatocellular Cancer

Genes & Cancer

August 22, 2022
PRESS RELEASE: A new research paper was published in Genes & Cancer on June 6, 2022, entitled, “Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer.” continue reading »